Effect of Induction Chemotherapy With Paclitaxel, Cisplatin, and Capecitabine vs Cisplatin and Fluorouracil on Failure-Free Survival for Patients With Stage IVA to IVB Nasopharyngeal Carcinoma-Reference-Cited by-同舟云学术

Effect of Induction Chemotherapy With Paclitaxel, Cisplatin, and Capecitabine vs Cisplatin and Fluorouracil on Failure-Free Survival for Patients With Stage IVA to IVB Nasopharyngeal Carcinoma

Published:2022-05-01 Issue:5 Volume:8 Page:706
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Li Wang-Zhong¹,Lv Xing¹,Hu Dan²,Lv Shu-Hui³,Liu Guo-Ying¹⁴,Liang Hu¹,Ye Yan-Fang⁵,Yang Wen⁶,Zhang Han-Xiong²,Yuan Tai-Ze⁷,Wang De-Shen⁸,Lu Nian⁹,Ke Liang-Ru⁹,Tang Wu-Bing⁶,Tong Li-Hua⁶,Chen Zhi-Jie²,Liu Ting²,Cao Ka-Jia¹,Mo Hao-Yuan¹,Guo Ling¹,Zhao Chong¹,Chen Ming-Yuan¹,Chen Qiu-Yan¹,Huang Pei-Yu¹,Sun Rui¹,Qiu Fang¹,Luo Dong-Hua¹,Wang Lin¹,Hua Yi-Jun¹,Tang Lin-Quan¹,Qian Chao-Nan⁷,Mai Hai-Qiang¹,Guo Xiang¹,Xiang Yan-Qun¹,Xia Wei-Xiong¹

Affiliation:

1. Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, the State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China

2. Department of Radiation Oncology, Center for Cancer Prevention and Treatment, Meizhou People’s Hospital, Meizhou Academy of Medical Sciences, Meizhou, China

3. Department of Ultrasound, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China

4. Department of Radiation Oncology, Sun Yat-sen Memorial Hospital, Guangzhou, China

5. Clinical Research Design Division, Sun Yat-sen Memorial Hospital, Guangzhou, China

6. Department of Radiation Oncology, Nanhai People’s Hospital, the Sixth Affiliated Hospital of South China University of Technology, Foshan, China

7. Department of Radiation Oncology, Guangzhou Concord Cancer Center, Guangzhou, China

8. Department of Medical Oncology, Sun Yat-sen University Cancer Center, the State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China

9. Department of Medical Imaging, Sun Yat-sen University Cancer Center, the State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2790563/jamaoncology_li_2022_oi_220005_1652478700.3399.pdf

Reference54 articles.

1. Nasopharyngeal carcinoma.;Chen;Lancet,2019

2. What is the best treatment of locally advanced nasopharyngeal carcinoma? an individual patient data network meta-analysis.;Ribassin-Majed;J Clin Oncol,2017

3. Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma.;Hui;J Clin Oncol,2009

4. Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial.;Sun;Lancet Oncol,2016

5. Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma—Taiwan Cooperative Oncology Group (TCOG) 1303 Study.;Hong;Ann Oncol,2018

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Camrelizumab and apatinib plus induction chemotherapy and concurrent chemoradiotherapy in stage N3 nasopharyngeal carcinoma: a phase 2 clinical trial;Nature Communications;2024-02-03

2. Phase I dose-escalation study of nab-paclitaxel combined with cisplatin and capecitabin as induction chemotherapy followed by concurrent chemoradiotherapy in patients with nasopharyngeal carcinoma;Radiotherapy and Oncology;2024-02

3. Embracing Personalized Strategies in Radiotherapy for Nasopharyngeal Carcinoma: Beyond the Conventional Bounds of Fields and Borders;Cancers;2024-01-16

4. Bulky glycocalyx shields cancer cells from invasion-associated stresses;Translational Oncology;2024-01

5. Indian clinical practice consensus guidelines for the management of nasopharyngeal cancer: Update 2022;Cancer Research, Statistics, and Treatment;2024